Home
>
US Stocks
>
Oramed Pharmaceuticals, Inc
Oramed Pharmaceuticals, Inc
ORMP

Oramed Pharmaceuticals, Inc (ORMP)

$23.040.52%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$22.98
Today Low/High$22.89 / $23.51
52 Week Low/High$2.4 / $24.25
Market Cap$745.22M

Company Details

Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery (POD™) technology. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary lead candidate, ORMD-0801, which has the potential to be the first commercial oral insulin capsulefor the treatment of diabetes. The Company has completed multiple Phase II clinical trials under an Investigational New Drug application with the U.S. Food and Drug Administration. In addition, Oramed is developing an oral GLP-1 (Glucagon-like peptide-1) analog capsule, ORMD-0901.
OrganisationOramed Pharmaceuticals, Inc
HeadquatersNew York, New York, US
Employees12
IndustryHealth Technology
CEONadav Kidron

Discover more

Frequently Asked Questions

What is Oramed Pharmaceuticals, Inc (ORMP) share price today?

Can Indians buy Oramed Pharmaceuticals, Inc (ORMP) shares?

How can I buy Oramed Pharmaceuticals, Inc (ORMP) shares from India?

Can Fractional shares of Oramed Pharmaceuticals, Inc (ORMP) be purchased?

What are the documents required to start investing in Oramed Pharmaceuticals, Inc (ORMP) stocks?

We are a SEBI registered investement advisor